Weichang'an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer-Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1.

Pan, Chuan-Fang; Zhang, Xi; Wang, Jing-Wen; Yang, Tao; Zhong, Linda L D; Shen, Ke-Ping

Pan, Chuan-Fang; Zhang, Xi; Wang, Jing-Wen; Yang, Tao; Zhong, Linda L D; Shen, Ke-Ping.

Afiliação

Pan CF; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhang X; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang JW; School of Nursing, Shengli College, China University of Petroleum, Dongying, China.
Yang T; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhong LLD; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Shen KP; Hong Kong Baptist University, Kowloon, Hong Kong.

Front Pharmacol ; 11: 512598, 2020.

Article em En | MEDLINE | ID: mdl-33746736

Palavras-chave

Weichang'An formula; angiogenesis; cancer; immunity; leptin/STAT3 signal pathway; traditional Chinese medicine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google